Intradiscal Steroid Offers Short-Term Relief of Lower Back Pain

Share this content:
Intradiscal Steroid Offers Short-Term Relief of Lower Back Pain
Intradiscal Steroid Offers Short-Term Relief of Lower Back Pain

TUESDAY, March 21, 2017 (HealthDay News) -- For patients with chronic low back pain (LBP) with active discopathy, a single glucocorticoid intradiscal injection (GC IDI) is associated with reduced LBP at one month but not 12 months after the intervention, according to a study published online March 21 in the Annals of Internal Medicine.

Christelle Nguyen, M.D., Ph.D., from the Université Paris Descartes, and colleagues examined the efficacy of GC IDI in patients with chronic LBP with active discopathy in a parallel-group randomized trial. One hundred thirty-five patients with chronic LBP with active discopathy on magnetic resonance imaging from three tertiary care centers in France were randomized to a single GC IDI during discography (67 patients) or discography alone (68 patients).

The researchers found that percentage of responders (LBP intensity <40 on an 11-point numerical rating scale) was higher in the GC IDI group than the control group at one month after the intervention (55.4 versus 33.3 percent; absolute risk difference, 22.1 percentage points; P = 0.009). There was no between-group difference in LBP intensity at 12 months; most secondary outcomes did not differ between the groups at one or 12 months.

"In chronic LBP associated with active discopathy, a single GC IDI reduces LBP at one month but not at 12 months," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »